Indefinite Delivery Contract SPE2DR25D6005

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is valued at $999,999,999 and runs through December 2036. It serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs,...
The Defense Logistics Agency (DLA) Troop Support awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract, which runs through December 2036, encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
The contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is an Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through December 2036. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
The Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. is a single-award contract valued at $999,999,999 through November 2026. This contract serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a broad spectrum of critical medical commodities, including...
This indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, aims to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The single-award IDC, valued at up to $999,999,999.00 and running through December 2025, serves as the primary vehicle for Amerisourcebergen to deliver essential medical commodities...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $999,999,999 Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This single-award IDC has a base period through December 2026, with the option to extend for an additional 10 years. The contract covers critical medical commodities including specialty medications,...
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. Under this contract, Amerisourcebergen provides...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp valued at $999,999,999 through November 2036. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs,...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, valued at $999,999,999, to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period with three 30-month option periods, for a total period of performance through November 2036. The IDC will serve as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, valued at $999,999,999 through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications,...

The Department of Defense awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This single-award IDC, issued by the Defense Logistics Agency (DLA) Troop Support Medical, has a period of performance through December 2036.

The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. It serves as the primary vehicle for DLA to procure essential pharmaceutical and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries. In addition, Amerisourcebergen holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement through a streamlined, comprehensive contracting mechanism.

Generated 6/6/25, 9:59 AM